BioLife Solutions Inc (BLFS)
Pretax margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -20,243 | -45,996 | -73,282 | -62,757 | -66,258 | -102,107 | -84,006 | -150,429 | -144,827 | -113,876 | -107,869 | -35,928 | -29,026 | -16,779 | -13,003 | -24,707 | -1,281 | 6,237 | 17,639 | 38,271 |
Revenue (ttm) | US$ in thousands | 102,868 | 122,972 | 125,729 | 136,909 | 142,796 | 154,008 | 161,427 | 162,452 | 161,032 | 154,468 | 147,521 | 138,192 | 118,837 | 96,581 | 74,057 | 52,773 | 48,087 | 41,249 | 36,673 | 33,590 |
Pretax margin | -19.68% | -37.40% | -58.29% | -45.84% | -46.40% | -66.30% | -52.04% | -92.60% | -89.94% | -73.72% | -73.12% | -26.00% | -24.43% | -17.37% | -17.56% | -46.82% | -2.66% | 15.12% | 48.10% | 113.94% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-20,243K ÷ $102,868K
= -19.68%
BioLife Solutions Inc's pre-tax margin has experienced significant fluctuations over the past few years. The pre-tax margin was exceptionally high at 113.94% in March 2020 but subsequently decreased to 48.10% in June 2020 and further declined to 15.12% in September 2020. By December 2020, the pretax margin turned negative at -2.66%, indicating that the company's expenses exceeded its pre-tax income.
The negative trend continued into the following periods, with pre-tax margins deteriorating significantly to -46.82% in March 2021 and bottoming out at -92.60% by March 2023. This indicates that BioLife Solutions Inc was incurring substantial losses in relation to its pre-tax income during these periods.
There appears to have been a slight improvement in the pre-tax margin as of December 2024, where it was recorded at -19.68%. However, it is still negative, suggesting that the company may be facing challenges in generating profits before accounting for taxes.
Overall, the analysis of BioLife Solutions Inc's pre-tax margin demonstrates a volatile and challenging financial performance in recent years, characterized by significant fluctuations and periods of negative profitability.
Peer comparison
Dec 31, 2024